<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05101993</url>
  </required_header>
  <id_info>
    <org_study_id>CP-2021-03</org_study_id>
    <nct_id>NCT05101993</nct_id>
  </id_info>
  <brief_title>VClip Post-Market Study</brief_title>
  <official_title>Long-term Follow-up on LAA Exclusion Using AtriClip</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AtriCure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AtriCure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective-prospective, multi-center, non-randomized, unblinded, post-market study to&#xD;
      evaluate the long-term performance and safety of AtriClip® FLEX-V LAA and PRO•V LAA Exclusion&#xD;
      devices for exclusion of the left atrial appendage of the heart during concomitant cardiac&#xD;
      procedures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Performance Endpoint</measure>
    <time_frame>12-months or greater post-procedure</time_frame>
    <description>Left Atrial Appendage exclusion defined as absence of residual communication (≤3 mm residual communication with LAA) between the left atrium (LA) and the LAA as assessed by CTA or TEE imaging at the last follow-up visit. The images will be reviewed by an independent core lab using a standardized imaging protocol.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Safety Endpoint</measure>
    <time_frame>30-days post-procedure</time_frame>
    <description>Incidence of the following serious adverse events within 30-days, if related tot he device and/or implant procedure:&#xD;
Death&#xD;
Ischemic Stroke&#xD;
Transient Ischemic Attack&#xD;
Systemic Embolism&#xD;
Hemorrhagic Stroke&#xD;
Major Bleeding (BARC 3 and above)&#xD;
Surgical site infection&#xD;
Pericardial effusion requiring intervention&#xD;
Clinical diagnosis of myocardial infarction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Performance</measure>
    <time_frame>12-months or greater post-procedure</time_frame>
    <description>A residual LAA neck ≤10 mm as assessed by CTA or TEE imaging at the last follow-up visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term thromboembolic events</measure>
    <time_frame>12-months or greater post-procedure</time_frame>
    <description>Incidence of thromboembolic events (ischemic stroke, TIA, systemic embolism) of any cause through the last follow-up visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device and Procedure long-term Safety</measure>
    <time_frame>12-months or greater post-procedure</time_frame>
    <description>Device or procedure related SAEs through the last follow-up visit</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Left Atrial Appendage Absent</condition>
  <arm_group>
    <arm_group_label>AtriClip group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AtriClip</intervention_name>
    <description>Received AtriClip for exclusion of left atrial appendage during concomitant cardiac procedure</description>
    <arm_group_label>AtriClip group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is greater than or equal to 18 years of age.&#xD;
&#xD;
          2. Subject who received the AtriClip FLEX-V or PRO•V implant during a non-emergent&#xD;
             cardiac surgical procedure&#xD;
&#xD;
          3. Subject is willing and able to provide written informed consent&#xD;
&#xD;
          4. Subject is willing and able to return for scheduled follow-up visit and imaging (CTA&#xD;
             or TEE)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability, unwillingness, or contraindication to undergo TEE or CTA imaging&#xD;
&#xD;
          2. Subjects who are pregnant or breast feeding&#xD;
&#xD;
          3. Subjects with active COVID-19 infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elias Zias, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pamela P Simons, BS, RT</last_name>
    <phone>650-241-6011</phone>
    <email>psimons@atricure.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rebecca Ikura, M.Eng, BS</last_name>
    <email>rikura@atricure.com</email>
  </overall_contact_backup>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 20, 2021</study_first_submitted>
  <study_first_submitted_qc>October 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

